CASI Pharmaceuticals
CASI
#11098
Rank
NZ$7.61 M
Marketcap
NZ$0.37
Share price
0.00%
Change (1 day)
-84.79%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.94. In 2024 the company made an earnings per share (EPS) of NZ-$4.57 a decrease over its 2023 EPS that were of NZ-$3.61.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.651.78%
2024NZ-$4.5726.73%
2023NZ-$3.61-32.89%
2022NZ-$5.3711.9%
2021NZ-$4.80-38.44%
2020NZ-$7.80-8.96%
2019NZ-$8.5750%
2018NZ-$5.7177.78%
2017NZ-$3.215.88%
2016NZ-$3.03-22.73%
2015NZ-$3.93-76.09%
2014NZ-$16.42318.18%
2013NZ-$3.93-71.79%
2012NZ-$13.9265.96%
2011NZ-$8.39-50%
2010NZ-$16.78-18.97%
2009NZ-$20.71-63.64%
2008NZ-$56.943.57%
2007NZ-$54.98-60.56%
2006NZ-$139.4297.22%
2005NZ-$70.69-2.7%
2004NZ-$72.65-45.59%
2003NZ-$133.53-61.8%
2002NZ-$349.52-25.52%
2001NZ-$469.30-21.38%
2000NZ-$596.9413.86%
1999NZ-$524.28149.53%
1998NZ-$210.1198.15%
1997NZ-$106.0410.2%
1996NZ-$96.22